Loading…
NeurAxis, Inc. is projected to rise to $7.00 by 2027, a +12% move from its current price of $6.25. NRXS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $6.09 | $6.25 | $6.42 | +0.01% |
| Aug 6 | $6.02 | $6.25 | $6.49 | +0.01% |
| Aug 7 | $5.97 | $6.25 | $6.54 | +0.02% |
| Aug 8 | $5.93 | $6.25 | $6.59 | +0.03% |
| Aug 9 | $5.90 | $6.25 | $6.63 | +0.03% |
| Aug 10 | $5.86 | $6.25 | $6.67 | +0.04% |
| Aug 11 | $5.83 | $6.25 | $6.70 | +0.05% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.83 | $6.25 | $6.70 | +0.05% |
| Week 2 | $5.67 | $6.26 | $6.90 | +0.09% |
| Week 3 | $5.55 | $6.26 | $7.06 | +0.14% |
| Week 4 | $5.45 | $6.26 | $7.19 | +0.18% |
| Week 5 | $5.37 | $6.26 | $7.31 | +0.23% |
| Week 6 | $5.29 | $6.27 | $7.43 | +0.27% |
| Week 7 | $5.22 | $6.27 | $7.53 | +0.32% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
NeurAxis, Inc. is a medical technology company focused on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms.
The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc.
and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.
NeurAxis, Inc. trades under the NRXS symbol in the Healthcare sector. The current price is $6.04 with a market cap of $75.36M and a market rank of 4333. The forecast presents a near-term path where 2026 shows an average price of $6.04 within a $4.21–$7.65 range, reflecting a neutral sentiment.
Over the longer horizon, the outlook becomes increasingly bullish, with the average price rising to $10.69 by 2030 and to $40.16 by 2050, delivering sizable upside (77.1% by 2030 and 564.9% by 2050).
A major floor 15.8% below — a decisive break under it would weaken the trend.
The nearest floor, 3.4% below — buyers have tended to step in here.
The nearest ceiling, 17.0% above — a clean break opens room to run.
A major ceiling 41.0% above — clearing it would confirm fresh momentum.
Key NRXS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NRXS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $6.37 | Sell | $6.37 | Sell |
| MA 10 | $6.64 | Sell | $6.54 | Sell |
| MA 20 | $6.83 | Sell | $6.73 | Sell |
| MA 50 | $6.97 | Sell | $6.92 | Sell |
| MA 100 | $7.20 | Sell | $6.69 | Sell |
| MA 200 | $5.53 | Buy | $5.84 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 37.47 | Neutral |
| Stoch RSI (14) | 30.74 | Neutral |
| CCI (20) | -155.96 | Sell |
| Williams %R (14) | -81.08 | Info |
| MACD (12,26,9) | -0.08 | Sell |
| ROC (12) | -10.46 | Sell |
| Bollinger %B (20,2) | 0.05 | Neutral |
| Stochastic %K (14) | 18.92 | Buy |
| TRIX (15) | -0.24 | Sell |
| Awesome (5,34) | -0.53 | Sell |
| Ultimate (7,14,28) | 32.04 | Neutral |
| Momentum (10) | -0.50 | Sell |
| Aroon Osc (25) | -80.00 | Sell |
| Hull MA (9) | 6.07 | Buy |
| ADX (14) | 12.73 | Neutral |
| ATR (14) | 0.17 | Info |
The near-term technical picture is Neutral. The RSI(14) is 30, and the 50-day simple moving average is $7.01 while the 200-day simple moving average is $5.49. The stock finds support at $6.04 and faces resistance at $7.31.
The 30-day price range spans from $5.07 to $7.20. The annualized volatility is about 50%, reflecting notable price movement potential within the month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.21 | $6.25 | $7.90 | 0% | Neutral | |
| $5.61 | $7.00 | $9.23 | +12% | Neutral | |
| $6.14 | $7.88 | $10.78 | +26% | Bullish | |
| $6.67 | $8.75 | $12.31 | +40% | Bullish | |
| $8.28 | $11.08 | $15.96 | +77% | Bullish | |
| $8.83 | $12.02 | $17.67 | +92% | Bullish | |
| $8.39 | $11.61 | $17.39 | +86% | Bullish | |
| $9.11 | $12.81 | $19.51 | +105% | Bullish | |
| $9.25 | $13.21 | $20.43 | +111% | Bullish | |
| $9.70 | $14.04 | $22.03 | +125% | Bullish | |
| $13.56 | $20.90 | $34.83 | +234% | Bullish | |
| $24.54 | $42.18 | $76.72 | +575% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $4.21 | $6.25 | $7.24 | +0.00% |
| September 2026 | $5.11 | $6.03 | $7.32 | -3.48% |
| October 2026 | $5.29 | $6.29 | $7.71 | +4.22% |
| November 2026 | $5.33 | $6.37 | $7.87 | +1.31% |
| December 2026 | $5.28 | $6.34 | $7.90 | -0.47% |
Click any year to see its month-by-month NRXS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
NeurAxis, Inc.'s 2026 outlook centres on $6.25, within a $4.21 to $7.90 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, NRXS could reach as high as $9.23, with a base case around $7.00 and support toward $5.61 — roughly +12% from $6.25. A consolidation phase looks the most probable path here.
Expect NRXS to range from $6.14 to $10.78 through 2028. The $7.88 average target implies a +26% move from current prices. That is up +13% on the projected 2027 average. Momentum favours further upside here.
The NRXS price prediction for 2029 points to an average of $8.75 (low $6.67, high $12.31) — a potential gain of +40% on today's $6.25. Buyers look set to stay in control over this stretch.
In 2030, NRXS is projected to trade between $8.28 and $15.96, averaging $11.08 — a potential gain of +77% from today's $6.25. That is up +27% on the projected 2029 average. Momentum favours further upside here.
NeurAxis, Inc.'s 2031 outlook centres on $12.02, within a $8.83 to $17.67 range. That is up +8% on the projected 2030 average. That marks a +92% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, NRXS could reach as high as $17.39, with a base case around $11.61 and support toward $8.39 — roughly +86% from $6.25. Momentum favours further upside here.
Expect NRXS to range from $9.11 to $19.51 through 2033. The $12.81 average target implies a +105% move from current prices. That is up +10% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The NRXS price prediction for 2034 points to an average of $13.21 (low $9.25, high $20.43) — a potential gain of +111% on today's $6.25. Momentum favours further upside here.
In 2035, NRXS is projected to trade between $9.70 and $22.03, averaging $14.04 — a potential gain of +125% from today's $6.25. That is up +6% on the projected 2034 average. Buyers look set to stay in control over this stretch.
NeurAxis, Inc.'s 2040 outlook centres on $20.90, within a $13.56 to $34.83 range. That is up +49% on the projected 2035 average. That marks a +234% change versus current levels. Momentum favours further upside here.
By 2050, NRXS could reach as high as $76.72, with a base case around $42.18 and support toward $24.54 — roughly +575% from $6.25. Buyers look set to stay in control over this stretch.
Investing $1,000 in NRXS today (≈ 160 NRXS) could be worth
$6,748.87
+$5,748.87 (+575%) by 2050 · US Dollar
Based on the average projected NRXS price of $42.18 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in NRXSwould be worth at today's price.
$1,000 invested in NRXS on Jul 31, 2025 (≈ 381.679406 NRXS) would be worth
$2,385.5
+$1,385.5 (+138.5%) today · 2.39× · US Dollar
Based on a NRXS entry price of $2.62 vs. today's $6.25.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $6.8 | $919.12 | -8.1% |
| 1 month ago | $7.08 | $882.77 | -11.7% |
| 3 months ago | $8.08 | $773.51 | -22.6% |
| 6 months ago | $4.42 | $1,414.03 | +41.4% |
| 1 year ago | $2.62 | $2,385.5 | +138.5% |
| All time (3.0y) ago | $6 | $1,041.67 | +4.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our NRXS forecast.
Our base-case forecast reaches $13.00 around 2034.
Implied market cap at $13.00: $162.21M
The multi-year forecast shows a bullish trajectory beyond 2026. In 2030, the average price is projected to be $10.69 with a max of $15.45 and a ROI of 77.1%, with a bullish sentiment. The 2035 forecast shows an average of $13.36 with a max of $21.06 and a ROI of 121.2%.
By 2040, the average is $19.77 (max $33.12) with a ROI of 227.4%. By 2050, the average price is $40.16 (max $73.49) and a ROI of 564.9%, maintaining a bullish sentiment. These figures illustrate a long-run growth path but are estimates, not guarantees, and carry inherent uncertainty and risk.
Tap a question to reveal the answer.
The forecast for 2030 shows an average price of $10.69 with a max of $15.45 and a ROI of 77.1%, with bullish sentiment.
The longer-term outlook is bullish, with progressively higher average prices and significant potential ROI by 2030–2050, but near-term sentiment is Neutral and these are estimates, not guarantees.
Yes—the 2030 max is projected at $15.45, with an average of $10.69 and ROI of 77.1%, though this remains an estimate and not a guarantee.
Current price is $6.04 and the market cap is $75.36M.
The 30-day range is from $5.07 to $7.20.
NeurAxis, Inc. Community Discussion
0Share your NeurAxis, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.